These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37610265)

  • 1. Multimodal Single-Cell Sequencing of B Cells in Primary Sjögren's Syndrome.
    Arvidsson G; Czarnewski P; Johansson A; Raine A; Imgenberg-Kreuz J; Nordlund J; Nordmark G; Syvänen AC
    Arthritis Rheumatol; 2024 Feb; 76(2):255-267. PubMed ID: 37610265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
    Tzioufas AG; Wassmuth R; Dafni UG; Guialis A; Haga HJ; Isenberg DA; Jonsson R; Kalden JR; Kiener H; Sakarellos C; Smolen JS; Sutcliffe N; Vitali C; Yiannaki E; Moutsopoulos HM
    Ann Rheum Dis; 2002 May; 61(5):398-404. PubMed ID: 11959762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of salivary anti-SSA/B antibodies for diagnosing primary Sjögren's syndrome.
    Wei P; Li C; Qiang L; He J; Li Z; Hua H
    Med Oral Patol Oral Cir Bucal; 2015 Mar; 20(2):e156-60. PubMed ID: 25475778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome.
    Barcellos KS; Nonogaki S; Enokihara MM; Teixeira MS; Andrade LE
    J Rheumatol; 2007 Jun; 34(6):1283-92. PubMed ID: 17552056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between autoantibody types and salivary gland hypofunction in patients with primary Sjögren's syndrome.
    Kim BE; Kwon JS; Choi JH; Park PG; Ahn HJ
    J Oral Pathol Med; 2023 Feb; 52(2):188-194. PubMed ID: 36183157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of clinical and immunological characteristics between primary Sjögren's syndrome patients with positive and negative anti-SSB antibody].
    Han YJ; Li CH; Chen XY; Zhao JX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1000-1006. PubMed ID: 38101780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome.
    Thorlacius GE; Hultin-Rosenberg L; Sandling JK; Bianchi M; Imgenberg-Kreuz J; Pucholt P; Theander E; Kvarnström M; Forsblad-d'Elia H; Bucher SM; Norheim KB; Johnsen SJA; Hammenfors D; Skarstein K; Jonsson MV; Baecklund E; Aqrawi LA; Jensen JL; Palm Ø; Morris AP; ; ; Meadows JRS; Rantapää-Dahlqvist S; Mandl T; Eriksson P; Lind L; Omdal R; Jonsson R; Lindblad-Toh K; Rönnblom L; Wahren-Herlenius M; Nordmark G
    Rheumatology (Oxford); 2021 Feb; 60(2):837-848. PubMed ID: 32889544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome.
    Aqrawi LA; Skarstein K; Øijordsbakken G; Brokstad KA
    Clin Exp Immunol; 2013 May; 172(2):228-37. PubMed ID: 23574319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-SSA/SSB-negative primary Sjögren's syndrome showing different clinical phenotypes: a retrospective study of 934 cases.
    Chen J; He Q; Yang J; Wu T; Huang Z; Zhang Y; Liao J; Zhang L; Yu X; Yao C; Luo J; Tao Q
    Adv Rheumatol; 2023 May; 63(1):21. PubMed ID: 37189182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of N-Glycosylation Sites in Immunoglobulin Heavy Chain Genes During Local Expansion in Parotid Salivary Glands of Primary Sjögren Patients.
    Visser A; Doorenspleet ME; de Vries N; Spijkervet FKL; Vissink A; Bende RJ; Bootsma H; Kroese FGM; Bos NA
    Front Immunol; 2018; 9():491. PubMed ID: 29662487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
    Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():701656. PubMed ID: 34413853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with Primary Sjögren's Syndrome Have Alterations in Absolute Quantities of Specific Peripheral Leucocyte Populations.
    Davies R; Hammenfors D; Bergum B; Jakobsen K; Solheim M; Vogelsang P; Brun JG; Bryceson Y; Jonsson R; Appel S
    Scand J Immunol; 2017 Dec; 86(6):491-502. PubMed ID: 29072325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
    ter Borg EJ; Kelder JC
    Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome.
    Yoshimoto K; Suzuki K; Takei E; Ikeda Y; Takeuchi T
    Arthritis Res Ther; 2020 Jun; 22(1):157. PubMed ID: 32576236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant signaling of immune cells in Sjögren's syndrome patient subgroups upon interferon stimulation.
    Sarkar I; Davies R; Aarebrot AK; Solberg SM; Petrovic A; Joshi AM; Bergum B; Brun JG; Hammenfors D; Jonsson R; Appel S
    Front Immunol; 2022; 13():854183. PubMed ID: 36072585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4
    Hong X; Meng S; Tang D; Wang T; Ding L; Yu H; Li H; Liu D; Dai Y; Yang M
    Front Immunol; 2020; 11():594658. PubMed ID: 33603736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
    Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
    Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
    Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
    Front Immunol; 2019; 10():1153. PubMed ID: 31191532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription profiling of peripheral B cells in antibody-positive primary Sjögren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature.
    Imgenberg-Kreuz J; Sandling JK; Björk A; Nordlund J; Kvarnström M; Eloranta ML; Rönnblom L; Wahren-Herlenius M; Syvänen AC; Nordmark G
    Scand J Immunol; 2018 May; 87(5):e12662. PubMed ID: 29655283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.